Biomet, a distributor of musculoskeletal medical products, has entered into an agreement to distribute Bonesupport's proprietary Cerament|Bone void Filler product line, designed for orthopedics, trauma and foot and ankle indications.
Under the agreement, Biomet has gained exclusive rights to distribute Bonesupport’s products in the US and Canada.
Bonesupport CEO Lloyd Diamond said the agreement is an important step in the company’s planned commercialization strategy to expand access and accelerate adoption of the Cerament product portfolio.
"Biomet’s leadership position and strong distribution channel provide full and immediate territory coverage for CERAMENT in two critical markets, the United States and Canada and provides an excellent platform from which we can launch future product line extensions," Diamond added.
Biomet Biologics vice president and general manager Joel Higgins said, "Not only does CERAMENT complement our existing portfolio of products, this agreement demonstrates our commitment to bring innovative products to market which offer better therapeutic options to our customers and improved care for their patients."